Stay updated on Pembrolizumab Combo in ES-SCLC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Combo in ES-SCLC Clinical Trial page.

Latest updates to the Pembrolizumab Combo in ES-SCLC Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedResults have been posted for NCT04924101 on 2026-07-01, with the page listing primary and secondary outcomes and related QoL and safety data per RECIST 1.1. The update also references the study protocol and statistical plan documents.SummaryDifference1%

- Check15 days agoChange DetectedThe page revision number was updated from v3.6.0 to v3.6.2, indicating underlying system or UI updates rather than changes to the study data.SummaryDifference0.0%

- Check29 days agoChange DetectedThe study page now states that recruitment is closed. Additionally, new sections such as 'How to Read a Study Record', 'Common Questions', and 'How to Join a Study' were added, and the revision label was updated to v3.6.0.SummaryDifference0.3%

- Check36 days agoChange DetectedThe study page now displays 'Results Submitted' and the page revision is updated to v3.5.5, indicating that results have been submitted. The previous status 'No Results Posted' and revision v3.5.4 are no longer shown.SummaryDifference0.1%

- Check58 days agoChange DetectedThe page revision was updated from v3.5.3 to v3.5.4, indicating a new published version of the page content.SummaryDifference0.0%

- Check80 days agoChange DetectedThe page’s displayed revision/version number has been updated from v3.5.2 to v3.5.3.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab Combo in ES-SCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in ES-SCLC Clinical Trial page.